Your account is not claimed yet. You can sign up with ORCID to claim your account.

Åsa H Everhov (Å H Everhov, Åsa Hallqvist Everhov)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Alimentary pharmacology & therapeutics

Cancer causes & control : CCC

Inflammatory bowel diseases

Clinical epidemiology

Karolinska Institutet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Karolinska Institutet

Sweden

PHD :: Department of Oncology-Pathology

Publications

Åsa H Everhov, Jonas Söderling, Gustaf Befrits, Hamed Khalili, Gabriella Bröms, Martin Neovius, null null, Johan Askling, Jonas Halfvarson, Jonas F Ludvigsson, Ola Olén
Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden. Alimentary pharmacology & therapeutics (2023)
Shabane Barot, Petri Rantanen, Caroline Nordenvall, Ulrik Lindforss, Åsa H Everhov, Susanna C Larsson, Annika Lindblom, Annelie Liljegren
Combined associations of a healthy lifestyle and body mass index with colorectal cancer recurrence and survival: a cohort study. Cancer causes & control : CCC (2023)
Åsa H Everhov, Rune Erichsen, Jacob Järås, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F Ludvigsson, Henrik Toft Sørensen, Ola Olén
Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study. Alimentary pharmacology & therapeutics 56 (7) (2022)
Petter Malmborg, Åsa H Everhov, Jonas Söderling, Jonas F Ludvigsson, Gustaf Bruze, Ola Olén
Earnings during adulthood in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study. Alimentary pharmacology & therapeutics 56 (6) (2022)
Åsa H Everhov, Ola Olén
Editorial: colorectal cancer in elderly-onset IBD-what is the risk? Authors' reply. Alimentary pharmacology & therapeutics 56 (9) (2022)
Åsa H Everhov, Thordis Disa Kalman, Jonas Söderling, Caroline Nordenvall, Jonas Halfvarson, Anders Ekbom, Jonas F Ludvigsson, Ola Olén, Pär Myrelid
Probability of Stoma in Incident Patients With Crohn's Disease in Sweden 2003-2019: A Population-based Study. Inflammatory bowel diseases (2021)
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, Hamed Khalili, Johan Askling, Martin Neovius, Pär Myrelid, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olén, null null
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study. Clinical epidemiology 12 (2020)
Åsa H Everhov, Rune Erichsen, Michael C Sachs, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F Ludvigsson, H T Sørensen, Ola Olén
Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017. Alimentary pharmacology & therapeutics 52 (1) (2020)
Hamed Khalili, Åsa H Everhov, Jonas Halfvarson, Jonas F Ludvigsson, Johan Askling, Pär Myrelid, Jonas Söderling, Ola Olen, Martin Neovius, null null
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden. Alimentary pharmacology & therapeutics 52 (4) (2020)
Åsa H Everhov, Jonas F Ludvigsson, Ola Olén
Letter: phenotype and natural history of elderly onset inflammatory bowel disease. Alimentary pharmacology & therapeutics 47 (10) (2019)

Åsa H Everhov.css-eqlu8i{font-size:small;padding-left:4px;} (Å H Everhov, Åsa Hallqvist Everhov)

Publication Activity (10 Years)

Top Topics

Top Venues

Åsa H Everhov (Å H Everhov, Åsa Hallqvist Everhov)